title: Increased levels of 2-hydroxyglutarate in AML patients with IDH1-R132H and IDH2-R140Q mutations.
authors.forename: Leopold
authors.initials: L
authors.lastname: Sellner
authors.forename: David
authors.initials: D
authors.lastname: Capper
authors.forename: Jochen
authors.initials: J
authors.lastname: Meyer
authors.forename: Claus-Dieter
authors.initials: CD
authors.lastname: Langhans
authors.forename: Christine-Maria
authors.initials: CM
authors.lastname: Hartog
authors.forename: Heike
authors.initials: H
authors.lastname: Pfeifer
authors.forename: Hubert
authors.initials: H
authors.lastname: Serve
authors.forename: Anthony D
authors.initials: AD
authors.lastname: Ho
authors.forename: Jürgen G
authors.initials: JG
authors.lastname: Okun
authors.forename: Alwin
authors.initials: A
authors.lastname: Krämer
authors.forename: Andreas
authors.initials: A
authors.lastname: Von Deimling
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005977:Glutarates / Q000032:analysis*; D006801:Humans; D007521:Isocitrate Dehydrogenase / Q000235:genetics*; D015470:Leukemia, Myeloid, Acute / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D020125:Mutation, Missense
chemical_list: D005977:Glutarates; C019417:alpha-hydroxyglutarate; C538784:IDH2 protein, human; D007521:Isocitrate Dehydrogenase; C543588:IDH1 protein, human